Cardiopulmonary bypass (CPB), which induces pulmonary injury, significantly impacts the quality of life in patients undergoing cardiac surgery. Preventing and treating pulmonary complications has become a critical clinical issue. Optimizing ventilation strategies during the preoperative, intraoperative, and postoperative stages is essential for adequate lung protection and preventing CPB-related pulmonary injury.
Methods
A comprehensive search of multiple databases including PubMed, Embase, and the Cochrane Library was conducted. After removing the duplicate studies, full-text review was performed, and all studies that reported mechanical ventilation strategies and lung protection during CPB were included.
Results
This review systematically examines ventilation strategies during CPB, outlining optimized parameters and pharmacologic approaches across pre-, intra-, and post-CPB phases to reduce lung injury. Various modes — including volume control ventilation (VCV), pressure control ventilation (PCV), and pressure-controlled ventilation–volume guaranteed (PCV-VG) — demonstrate unique benefits and limitations. When combined with protective measures (low tidal volume [LTV], moderate positive end-expiratory pressure [PEEP], and recruitment maneuvers), they show clinical efficacy in lung protection. Pharmacologic agents like ambroxol, neutrophil elastase inhibitors, and sivelestat further enhance protection, underscoring the promise of combined mechanical-pharmacological strategies against CPB-induced lung injury.
Conclusions
A comprehensive approach integrating individualized ventilation management and pharmacological intervention is key to reducing CPB-induced lung injury, enhancing postoperative respiratory function, and improving patient outcomes.
IsmailASemienGSharmaS, et al.Cardiopulmonary bypass. 2024. Aug 12. In: StatPearls. StatPearls Publishing, 2025.
2.
NteliopoulosGNikolakopoulouZChowBHN, et al.Lung injury following cardiopulmonary bypass: a clinical update. Expert Rev Cardiovasc Ther2022; 20(11): 871–880.
3.
LiHZhangWLouQ, et al.XueFu ZhuYu decoction alleviates cardiopulmonary bypass-induced NLRP3 inflammasome-dependent pyroptosis by inhibiting IkB-α/NF-κB pathway in acute lung injury rats. Evid Based Complement Alternat Med2022; 2022: 6248870.
4.
TriccoACLillieEZarinW, et al.PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med2018; 169(7): 467–473.
5.
AbbottMPereiraSMSandersN, et al.Weaning from mechanical ventilation in the operating room: a systematic review. Br J Anaesth2024; 133(2): 424–436.
6.
RichardJMBeloncleFMBéduneauG, et al.Pressure control plus spontaneous ventilation versus volume assist-control ventilation in acute respiratory distress syndrome. A randomized clinical trial. Intensive Care Med2024; 50(10): 1647–1656.
7.
HussainNSMetryAANakhlaGM, et al.Comparative study between different modes of ventilation during cardiopulmonary bypass and its effect on postoperative pulmonary dysfunction. Anesth Essays Res2019; 13(2): 236–242.
LiGMaSShuQ, et al.PCV-VG combined individualized PEEP determination in one-lung ventilated patients with PEEP step change direction: a randomized controlled trial. Clin Respir J2024; 18(1): e13696.
11.
YaoWYangMChengQ, et al.Effect of pressure‐controlled ventilation‐volume guaranteed on one‐lung ventilation in elderly patients undergoing thoracotomy. Med Sci Monit2020; 26: e921417.
12.
LiXFMaoWJJiangRJ, et al.Effect of mechanical ventilation mode type on postoperative pulmonary complications after cardiac surgery: a randomized controlled trial. J Cardiothorac Vasc Anesth2024; 38(2): 437–444.
13.
ParkMAhnHJKimJA, et al.Driving pressure during thoracic surgery: a randomized clinical trial. Anesthesiology2019; 130(3): 385–393.
14.
SunTTChenKXTaoY, et al.Effect of flow-optimized pressure control ventilation-volume guaranteed (PCV-VG) on postoperative pulmonary complications: a consort study. J Cardiothorac Surg2024; 19(1): 425.
15.
OrakYBaylanFAKocaslanA, et al.Effect of mechanical ventilation during cardiopulmonary bypass on oxidative stress: a randomized clinical trial. Braz J Anesthesiol2022; 72(1): 69–76.
16.
MillingtonSJCardinalPBrochardL. Setting and titrating positive end-expiratory pressure. Chest2022; 161(6): 1566–1575.
BuonannoPMarraAIacovazzoC, et al.Impact of ventilation strategies on pulmonary and cardiovascular complications in patients undergoing general anaesthesia for elective surgery: a systematic review and meta-analysis. Br J Anaesth2023; 131(6): 1093–1101.
19.
KankılıçNAydınMSGözM. The effect of low tidal volume ventilation on inflammatory cytokines during cardiopulmonary bypass. Braz J Cardiovasc Surg2022; 37(5): 694–701.
20.
ZhangMQLiaoYQYuH, et al.Effect of ventilation strategy during cardiopulmonary bypass on postoperative pulmonary complications after cardiac surgery: a randomized clinical trial. J Cardiothorac Surg2021; 16(1): 319.
21.
LagierDZengCFernandez-BustamanteA, et al.Perioperative pulmonary atelectasis: part II. Clinical implications. Anesthesiology2022; 136(1): 206–236.
22.
NguyenLSMerzougMEstagnasieP, et al.Low tidal volume mechanical ventilation against no ventilation during cardiopulmonary bypass heart surgery (MECANO): study protocol for a randomized controlled trial. Trials2017; 18(1): 582.
23.
ZupancichEPaparellaDTuraniF, et al.Mechanical ventilation affects inflammatory mediators in patients undergoing cardiopulmonary bypass for cardiac surgery: a randomized clinical trial. J Thorac Cardiovasc Surg2005; 130: 378–383.
24.
SteinbergIBisciaioARosbochGL, et al.Impact of intubated vs. non-intubated anesthesia on postoperative diaphragmatic function: results from a prospective observational study. Front Physiol2022; 13: 953951.
25.
SalterRParmarJAlywardL, et al.Association of passive lung insufflation oxygen fraction in adult patients on cardiopulmonary bypass with postoperative pulmonary outcomes: a retrospective cohort study. J Cardiothorac Vasc Anesth2022; 36(2): 461–468.
26.
SaundersHKhadkaSShresthaR, et al.The association between non-invasive ventilation and the rate of ventilator-associated pneumonia. Diseases2023; 11(4): 151.
27.
ZhangCBaiHZhangY, et al.Impact of body mass index on postoperative oxygenation impairment in patients with acute aortic syndrome. Front Physiol2022; 13: 955702.
28.
BeckerSSchnitzlerRRembeckiM, et al.Individualized flow-controlled versus conventional pressure-controlled ventilation in on-pump heart surgery (FLOWVENTIN HEARTSURG): study protocol for a randomized controlled trial. Trials2023; 24(1): 195.
29.
PadalinoMAVedovelliLSimonatoM, et al.Protective continuous ventilation strategy during cardiopulmonary bypass in children undergoing surgery for congenital heart disease: a prospective study. Interact Cardiovasc Thorac Surg2022; 35(2): ivac084.
30.
KaracalilarMOnanISOnanB, et al.Effects of pulmonary perfusion during cardiopulmonary bypass on lung functions after cardiac operation. J Card Surg2020; 35(10): 2469–2476.
31.
RobertsADuncanECHargraveP, et al.Complications of cardiopulmonary bypass from an anesthesia perspective: a clinical review. HCA Healthc J Med2023; 4(1): 13–21.
32.
BanavasiHNguyenPOsmanH, et al.Management of ARDS - what works and what does not. Am J Med Sci2021; 362(1): 13–23.
33.
WangLLiJZhuY, et al.Low tidal volume ventilation alleviates ventilator-induced lung injury by regulating the NLRP3 inflammasome. Exp Lung Res2022; 48(4-6): 168–177.
34.
GrantMCCrisafiCAlvarezA, et al.Perioperative care in cardiac surgery: a joint consensus statement by the enhanced recovery after surgery (ERAS) cardiac society, ERAS international society, and the society of thoracic surgeons (STS). Ann Thorac Surg2024; 117(4): 669–689.
35.
LiLDuLChenG, et al.Stroke volume variation induced by lung recruitment maneuver to predict fluid responsiveness in patients receiving mechanical ventilation: a systematic review and meta-analysis. J Clin Anesth2024; 97: 111545.
36.
ChenLDel SorboLGriecoDL, et al.Potential for lung recruitment estimated by the recruitment-to-inflation ratio in acute respiratory distress syndrome. A clinical trial. Am J Respir Crit Care Med2020; 201(2): 178–187.
37.
BattagliniDFazziniBSilvaPL, et al.Challenges in ARDS definition, management, and identification of effective personalized therapies. J Clin Med2023; 12(4): 1381.
38.
RozéHBonnardelEGalloE, et al.Inter-lung asymmetrical airway closure cause insufflation delay between lungs in acute hypoxemic respiratory failure. Ann Intensive Care2024; 14(1): 162.
39.
SpiegelRHocksteinM. Airway pressure release ventilation: a field guide for the emergency physician. Emerg Med Clin North Am2022; 40(3): 489–501.
40.
MalloryPCheifetzI. A comprehensive review of the use and understanding of airway pressure release ventilation. Expert Rev Respir Med2020; 14(3): 307–315.
41.
GeHLinLXuY, et al.Airway pressure release ventilation mode improves circulatory and respiratory function in patients after cardiopulmonary bypass, a randomized trial. Front Physiol2021; 12: 684927.
42.
FredericksASBunkerMPGligaLA, et al.Airway pressure release ventilation: a review of the evidence, theoretical benefits, and alternative titration strategies. Clin Med Insights Circ Respir Pulm Med2020; 14: 1179548420903297.
43.
RobertsA. Understanding the principles of non-invasive positive pressure ventilation. Nurs Stand2021; 36(8): 61–66.
44.
De JongAWriggeHHedenstiernaG, et al.How to ventilate obese patients in the ICU. Intensive Care Med2020; 46(12): 2423–2435.
45.
LeeSJangEAHongM, et al.Ramped versus sniffing position in the videolaryngoscopy-guided tracheal intubation of morbidly obese patients: a prospective randomized study. Korean J Anesthesiol2023; 76(1): 47–55.
46.
SalomonJDQiuHFengD, et al.Piglet cardiopulmonary bypass induces intestinal dysbiosis and barrier dysfunction associated with systemic inflammation. Dis Model Mech2023; 16(5): dmm049742.
47.
RabecCFresnelERétoryY, et al.Addition of bacterial filter alters positive airway pressure and non-invasive ventilation performances. Eur Respir J2022; 59(4): 2102636.
48.
VlastosDZeinahMNinkovic-HallG, et al.The effects of ischaemic conditioning on lung ischaemia-reperfusion injury. Respir Res2022; 23(1): 351.
49.
ZhangSLiJWangJ, et al.Ferroptosis exists in ischemia reperfusion injury after cardiac surgery with cardiopulmonary bypass. Cell Biochem Biophys2024; 82(2): 777–786.
50.
DengFZhaoBCYangX, et al.The gut microbiota metabolite capsiate promotes Gpx4 expression by activating TRPV1 to inhibit intestinal ischemia reperfusion-induced ferroptosis. Gut Microbes2021; 13(1): 1–21.
51.
SandeepBXiaoZZhaoF, et al.Role of platelets in acute lung injury after extracorporeal circulation in cardiac surgery patients: a systemic review. Curr Probl Cardiol2022; 47(11): 101088.
52.
ImuraHCaputoMLimK, et al.Pulmonary injury after cardiopulmonary bypass: beneficial effects of low-frequency mechanical ventilation. J Thorac Cardiovasc Surg2009; 137(6): 1530–1537.
53.
WangYHYanZZLuoSD, et al.Gut microbiota-derived succinate aggravates acute lung injury after intestinal ischemia/reperfusion in mice. Eur Respir J2023; 61(2): 2200840.
54.
LiJGaoPFXuYX, et al.Probiotic saccharomyces boulardii attenuates cardiopulmonary bypass-induced acute lung injury by inhibiting ferroptosis. Am J Transl Res2022; 14(7): 5003–5013.
55.
CooneySJKlawitterJKhailovaL, et al.Regional lung metabolic profile in a piglet model of cardiopulmonary bypass with circulatory arrest. Metabolomics2021; 17(10): 89.
56.
KongMWeiDLiX, et al.The dynamic changes in autophagy activity and its role in lung injury after deep hypothermic circulatory arrest. J Cell Mol Med2022; 26(4): 1113–1127.
57.
KhailovaLRobisonJJaggersJ, et al.Tissue alkaline phosphatase activity and expression in an experimental infant swine model of cardiopulmonary bypass with deep hypothermic circulatory arrest. J Inflamm (Lond)2020; 17: 27.
58.
PanTTuoerxunTChenX, et al.The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass. Front Immunol2023; 14: 1082830.
59.
ZhangJLiJAnZ, et al.Hydromorphone mitigates cardiopulmonary bypass-induced acute lung injury by repressing pyroptosis of alveolar macrophages. Shock2023; 60(1): 92–99.
60.
XuZZhangSZhangY, et al.[The mechanism of xuebijing injection in preventing and treating lung injury induced by cardiopulmonary bypass by regulating the apoptosis of alveolar polymorphonuclear neutrophil]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2024; 36(2): 166–171.
61.
ZhengXMYangZYangGL, et al.Lung injury after cardiopulmonary bypass: alternative treatment prospects. World J Clin Cases2022; 10(3): 753–761.
62.
LiJDouXLiD, et al.Dexmedetomidine ameliorates Post-CPB lung injury in rats by activating the PI3K/Akt pathway. J Invest Surg2020; 33(6): 576–583.
63.
FujiiMBesshoR. Neutrophil elastase inhibitor sivelestat attenuates myocardial injury after cardioplegic arrest in rat hearts. Ann Thorac Cardiovasc Surg2020; 26(5): 263–269.
64.
KaskinenAKKeski-NisulaJMarteliusL, et al.Lung injury after neonatal congenital cardiac surgery is mild and modifiable by corticosteroids. J Cardiothorac Vasc Anesth2021; 35(7): 2100–2107.
65.
LiXLuoYCaiX, et al.Anti-inflammatory effect of colchicine on organ damage during the perioperative period of cardiac surgery: a study protocol for a multicentre, randomized, double-blind, placebo-controlled clinical trial. BMJ Open2024; 14(9): e084368.
66.
HanDSunJFanD, et al.Simvastatin ameliorates oxygen glucose deprivation/reoxygenation-induced pulmonary endothelial barrier dysfunction by restoring cell-cell junctions and actin cytoskeleton dynamics via the PI3K/Akt signaling pathway. Am J Transl Res2020; 12(9): 5586–5596.
